IAP104 - Assessment of Pharmacokinetic Changes Following Concurrent Administration of Sufentanil NanoTab and Ketoconazole in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 06 Nov 2016
Price : $35 *
At a glance
- Drugs Sufentanil (Primary) ; Ketoconazole
- Indications Acute pain; Cancer pain; Postoperative pain
- Focus Pharmacokinetics
- Sponsors AcelRx Pharmaceuticals
- 31 Dec 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 10 Dec 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 08 Dec 2012 New trial record